A Cross-sectional Survey of Physicians to Understand Biomarker Testing and Treatment Patterns in Patients with Prostate Cancer in the USA, EU5, Japan, and China
Background and objective: Treatment landscape in advanced prostate cancer (PC) is evolving. There is limited understanding of the factors influencing decision-making for genetic/genomic testing and the barriers to recommending testing and treatment in international real-world clinical practice follo...
Saved in:
| Main Authors: | Christian Gratzke, Himani Aggarwal, Jeri Kim, Holly Chaignaud, Sabine Oskar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | European Urology Open Science |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168324006153 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upfront maintenance poly(Adenosine Diphosphate Ribose) polymerase inhibitors in ovarian cancer: A ray of hope or just a mirage!
by: Avinash Pandey, et al.
Published: (2020-01-01) -
Natural pentafuranosylnucleos(t)ides and their analogs: structure, functions, synthesis, and perspective of medical application
by: Dmitrii Platov, et al.
Published: (2025-05-01) -
PARP inhibitors elicit a cellular senescence mediated inflammatory response in homologous recombination proficient cancer cells
by: Misato Kamii, et al.
Published: (2025-05-01) -
PARP inhibitors are a new area in the treatment of breast cancer
by: V. P. Letyagin
Published: (2014-08-01) -
PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil
by: Aknar FC Calabrich, et al.
Published: (2023-04-01)